Metronidazol Polpharma

Metronidazole, the active ingredient in Metronidazol Polpharma, is a nitroimidazole antibiotic presented as a vaginal formulation for local use. It treats bacterial vaginosis, trichomoniasis and other anaerobic vaginal infections in women. The medication is indicated for adult female patients and is administered directly to the affected area.

GNH USA supplies Metronidazol Polpharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product complies with EU quality standards and is manufactured under GMP conditions.

Metronidazole is used to treat infections caused by anaerobic bacteria and protozoa in the vaginal tract.

- Bacterial vaginosis: restores normal vaginal flora by eliminating anaerobic bacteria. - Trichomoniasis: eradicates Trichomonas vaginalis, relieving symptoms and preventing transmission. - Other anaerobic vaginal infections: treats less common anaerobic pathogens, reducing inflammation and discharge.

Metronidazole may cause a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Metallic taste: transient metallic sensation in the mouth. - Vaginal irritation: local burning or itching. - Headache: mild to moderate headache.

Serious or Rare Side Effects: - Seizures: rare neurologic events requiring immediate care. - Stevens‑Johnson syndrome: severe skin reaction with blistering. - Peripheral neuropathy: tingling or numbness in extremities. - Anaphylaxis: life‑threatening allergic reaction with airway compromise.

Before prescribing Metronidazol Polpharma, consider the following precautions. - Pregnancy: Use only if clearly needed; safety not established. - Breastfeeding: Caution; drug may be excreted in milk. - Liver disease: Adjust use; drug is metabolized hepatically. - Alcohol consumption: Avoid; may cause a disulfiram‑like reaction. - Store below 25°C: keep in original pack, protect from moisture.

Metronidazol Polpharma can interact with several medicines; review patient medication lists.

Major Interactions (Avoid): - Alcohol: causes severe flushing, nausea, tachycardia. - Warfarin: may increase anticoagulant effect, raising bleeding risk. - Lithium: can raise lithium levels, leading to toxicity.

Moderate Interactions (Monitor Closely): - Cimetidine: may increase metronidazole plasma concentrations. - Phenytoin: may reduce metronidazole effectiveness. - Oral contraceptives: may reduce efficacy; advise backup contraception.